The Dynamic Use of EGFR Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer Patients

Epidermal growth factor receptor (EGFR) mutational testing in advanced non-small-cell lung cancer (NSCLC) is usually performed in tumor tissue, although cfDNA (cell-free DNA) could be an alternative. We evaluated EGFR mutations in cfDNA as a complementary tool in patients, who had already known EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Macías, Mónica, Alegre, Estibaliz, Alkorta-Aranburu, Gorka, Patiño-García, Ana, Mateos, Beatriz, Andueza, Maria P., Gúrpide, Alfonso, Lopez-Picazo, Jose M., Gil-Bazo, Ignacio, Perez-Gracia, Jose L., González, Álvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364099/
https://www.ncbi.nlm.nih.gov/pubmed/30809319
http://dx.doi.org/10.1155/2019/7954921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364099/
https://www.ncbi.nlm.nih.gov/pubmed/30809319
http://dx.doi.org/10.1155/2019/7954921

Ejemplares similares